FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

V Duchatelle

Research Profile

Living Beings

Hepacivirus

Chemicals & Drugs

Disorders

Concepts & Ideas

Anatomy

Livers

Activities & Behaviors

Procedures

Biopsy

Physiology

Genotype

Co-author Network

Publications

TOP 3
Fabienne Pessione; Marie-José Ramond; Corinne Njapoum; V Duchatelle; Claude Degott; S Erlinger; Bernard Rueff; Dominique-Charles Valla; Françoise Degos
Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.
Michèle Martinot-Peignoux; Nathalie Boyer; M Pouteau; Corinne Castelnau; Nathalie Giuily; V Duchatelle; A Aupérin; Claude Degott; Jean-Pierre Benhamou; S Erlinger; Patrick Marcellin
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
V Duchatelle; Patrick Marcellin; E Giostra; L Bregeaud; M Pouteau; Nathalie Boyer; A Auperin; S Guerret; S Erlinger; D Henin; Claude Degott
Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of V Duchatelle (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Fabienne Pessione; Marie-José Ramond; Corinne Njapoum; V Duchatelle; Claude Degott; S Erlinger; Bernard Rueff; Dominique-Charles Valla; Françoise Degos
Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2001;34(1):121-5.
1998: Michèle Martinot-Peignoux; Nathalie Boyer; M Pouteau; Corinne Castelnau; Nathalie Giuily; V Duchatelle; A Aupérin; Claude Degott; Jean-Pierre Benhamou; S Erlinger; Patrick Marcellin
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.
Journal of hepatology 1998;29(2):214-23.
1998: V Duchatelle; Patrick Marcellin; E Giostra; L Bregeaud; M Pouteau; Nathalie Boyer; A Auperin; S Guerret; S Erlinger; D Henin; Claude Degott
Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method.
Journal of hepatology 1998;29(1):20-8.
1998: Fabienne Pessione; Françoise Degos; Patrick Marcellin; V Duchatelle; Corinne Njapoum; Michèle Martinot-Peignoux; Claude Degott; Dominique Valla; S Erlinger; Bernard Rueff
Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.
Hepatology (Baltimore, Md.) 1998;27(6):1717-22.
1996: P Mathurin; V Duchatelle; M J Ramond; Claude Degott; P Bedossa; S Erlinger; Jean-Pierre Benhamou; J C Chaput; B Rueff; T Poynard
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone.
Gastroenterology 1996;110(6):1847-53.
1995: Patrick Marcellin; M Pouteau; Michèle Martinot-Peignoux; Françoise Degos; V Duchatelle; Nathalie Boyer; C Lemonnier; Claude Degott; S Erlinger; Jean-Pierre Benhamou
Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.
Gastroenterology 1995;109(1):156-65.
1994: Patrick Marcellin; Nathalie Boyer; Claude Degott; Michèle Martinot-Peignoux; V Duchatelle; E Giostra; J Areias; S Erlinger; Jean-Pierre Benhamou
Long-term histologic and viral changes in patients with chronic hepatitis C who responded to alpha interferon.
Liver 1994;14(6):302-7.